The newly formed citrate leaves the mitochondria, where it is used to synthesize fatty acids and amino acids and produce the reducing agent NADPH (cataplerosis)
SAN DIEGO Treatment with glucagon-like peptide-1 receptor agonists significantly reduced alanine aminotransferase among children with metabolic dysfunction-associated steatotic liver disease, especially those with type 2 diabetes
10.3389/fphar.2022.929262 Summary Keywords trimethylamine N-oxide, gut microbiota, chronic diseases, traditional Chinese medicine, inflammation, oxidative stress, metabolic disorders Citation Qin Z, Wu W, Yang X, Wang X, Ding A, Huang Y, Tang J, Jiang S, Zhang P, Qian C, Zhang X, Zhou S, Wang Y, Song Z, Sun M, Wang M, Shen S and Zhu B (2025) The role of trimethylamine N-oxide in disease pathogenesis and the therapeutic potential of traditional Chinese medicine
Data for these treatments are limited, and they are elective not medically necessary